Back
Methods for Development of the European Commission Initiative on Breast Cancer Guidelines: Recommendations in the Era of Guideline Transparency.
Journal article

Methods for Development of the European Commission Initiative on Breast Cancer Guidelines: Recommendations in the Era of Guideline Transparency.

  • Schünemann HJ McMaster University Health Sciences Centre, Hamilton, Ontario, Canada (H.J.S.).
  • Lerda D European Commission, Joint Research Centre, Ispra, Italy (D.L., N.D., Z.S.).
  • Dimitrova N European Commission, Joint Research Centre, Ispra, Italy (D.L., N.D., Z.S.).
  • Alonso-Coello P Iberoamerican Cochrane Centre, Barcelona, Spain (P.A.).
  • Gräwingholt A Radiologie am Theater, Paderborn, Germany (A.G.).
  • Quinn C St. Vincent's University Hospital, Dublin, Ireland (C.Q.).
  • Follmann M German Cancer Society, Berlin, Germany (M.F.).
  • Mansel R Cardiff University, Cardiff, United Kingdom (R.M.).
  • Sardanelli F Università degli Studi di Milano, Milan, Italy (F.S.).
  • Rossi PG Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy (P.G.R.).
  • Lebeau A University Medical Center Hamburg-Eppendorf, Hamburg, and Private Group Practice for Pathology, Lübeck, Germany (A.L.).
  • Nyström L Umeå University, Umeå, Sweden (L.N.).
  • Broeders M Radboud University Medical Centre, Nijmegen, Netherlands (M.B.).
  • Ioannidou-Mouzaka L University of Athens Medical School, Athens, Greece (L.I.).
  • Duffy SW Queen Mary University of London, London, United Kingdom (S.W.D.).
  • Borisch B Institute of Global Health. University of Geneva, Geneva, Switzerland (B.B.).
  • Fitzpatrick P National Screening Service, Dublin, Ireland (P.F.).
  • Hofvind S Cancer Registry of Norway, Oslo, Norway (S.H.).
  • Castells X IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain (X.C.).
  • Giordano L CPO-Piedmont - AOU Città della Salute e della Scienza, Torino, Italy (L.G.).
  • Warman S Langford, North Somerset, United Kingdom (S.W.).
  • Saz-Parkinson Z European Commission, Joint Research Centre, Ispra, Italy (D.L., N.D., Z.S.).
Show more…
  • 2019-07-23
Published in:
  • Annals of internal medicine. - 2019
Breast Neoplasms
Early Detection of Cancer
Europe
Evidence-Based Medicine
Female
Humans
Mass Screening
Practice Guidelines as Topic
English Neither breast cancer prevention and early-detection programs, nor their outcomes, are uniform across Europe. This article describes the rationale, methods, and process for development of the European Commission (EC) Initiative on Breast Cancer Screening and Diagnosis Guidelines. To be consistent with standards set by the Institute of Medicine and others, the EC followed 6 general principles. First, the EC selected, via an open call, a panel with broad representation of areas of expertise. Second, it ensured that all recommendations were supported by systematic reviews. Third, the EC separately considered important subgroups of women, included patient advocates in the guidelines development group, and focused on good communication to inform women's decisions. Fourth, EC rules on conflicts of interest were followed and the GRADE (Grading of Recommendations Assessment, Development and Evaluation) Evidence to Decision frameworks were used to structure the process and minimize the influence of competing interests. Fifth, it focused its recommendations on outcomes that matter to women, and certainty of the evidence is rated for each. Sixth, the EC elicited stakeholder feedback to ensure that the recommendations remain up to date and relevant to practice. This article describes the approach and highlights ways of disseminating and adapting the recommendations both within and outside Europe, using innovative information technology tools.
Language
  • English
Open access status
closed
Identifiers
Persistent URL
https://sonar.rero.ch/global/documents/100644
Statistics
Document views: 15 File downloads: